Pilulka's Market Expansion and Innovation slide image

Pilulka's Market Expansion and Innovation

Capital expenditure (CZK million) Operating expenses (CZK billion) 5.2 OPERATING EXPENSES AND CAPITAL EXPENDITURE Historical and estimated operating expenses (OpEx) Actuals | Forecast 29% 1.2 27% 30% 26% 26% 26% 0.9 24% 27% 23% 0.6 0.3 24% 21% 0.0 18% 2020 2021 2022 2023 2024 2025 2026 Warehouse Transport Marketing Other OpEx / Revenues Historical and estimated capital expenditure (CapEx) Actuals | Forecast 100 75 1% 50 25 0 4% 3% 3% 3% 2% 1% 1% 1% 2% 1% 0% 2020 2021 2022 2023 2024 2025 2026 â– Technology & IT Warehouse Plus Care Other CapEx / Revenues Note: The presented financial data are based on the Company's management accounting CapEx / Revenues OpEx / Revenues Warehousing, transport and marketing expenses are the main operating expenses of Pilulka Pilulka's ratio of operating expenses to total revenues is decreasing due to the Company's increasing operational efficiency and economies of scale The Company expects an overall decline capital expenditure between 2023 - 2026 in The share of capital expenditure on Pilulka's revenues also decreases in the forecast period, due to lower planned investments in technology & IT and mainly due to minimization of further investments in warehouse capacities (as they are now fully developed and invested). The newly expanded warehouse capacities in the Czech Republic and Slovakia will serve for local organic growth and at the same time as a base for expansion into Austria and Hungary 20 +pilulka
View entire presentation